Humpback whales can give birth while migrating thousands of miles
Humpback whales (Megaptera novaeangliae) are master migrators. Some populations of this baleen whale species travel upwards of 5,000 miles per year from colder waters to feed, towards warmer tropical waters where they give birth and care for their calves.
However, new research on a population off Australia's eastern coast indicates that their trips to more balmy waters are not as essential to calving as biologists thought. Calves in this population can actually be born in colder waters near New Zealand or Tasmania–about 932 miles further south (1,500 kilometers) than previously known. Understanding this pattern could challenge some long-held beliefs about humpback migration and improve protection areas to help these baby whales. The findings are detailed in a study published May 20 in the journal Frontiers in Marine Science.
'Hundreds of humpback calves were born well outside the established breeding grounds,' said Tracey Rogers, a study co-author and marine ecologist at the University of New South Wales in Australia. 'Giving birth along the 'humpback highway' means these vulnerable calves, who are not yet strong swimmers, are required to swim long distances much earlier in life than if they were born in the breeding grounds.'
In the Northern Hemisphere, humpback whales like those found on the east coast of the United States and Canada, typically migrate from colder feeding in the Northern Atlantic Ocean in the summer and south to the Caribbean for the winter to breed and calf.
For Southern Hemisphere humpbacks like those off the coast of Eastern Australia, the directions are flipped because of the equator. They travel from their frigid feeding grounds in the Southern Ocean around Antarctica, north towards the Pacific Ocean in Australia to breed, calve, and care for their young.
Finding this new baby whale hotspot arose due to study co-author and University of New South Wales Ph.D candidate Jane McPhee-Frew's extracurricular work as a marine guide.
'In July 2023, during a whale-watching tour, I encountered a mum and calf at the mouth of Newcastle Harbor—the busiest shipping port in Eastern Australia,' said McPhee-Frew. 'The calf was tiny, obviously brand new. What were they doing there? But none of my tourism colleagues seemed surprised.'
This new sighting piqued researchers' interest and they began investigating the calving range for humpback whales located around Australia and New Zealand. They used data from citizen science observations, government surveys, and reported strandings. New Zealand's Department of Conservation Cook Strait Whale Project supplied data from migration surveys, and Australian state wildlife departments supplied information on strandings dating all the way back to 1991.
The team found 209 records of newborn calves (including 11 births), 41 strandings, and 168 observations of live calves, representing at least 169 individual whales. They also had data on the direction of travel for 118 whales, which showed the whales were continuing to migrate north after delivery.
'Humpback whale populations undertake extensive long-distance migrations from the Southern Ocean to breeding grounds in the tropics,' said study co-author Adelaide Dedden of the National Parks and Wildlife Service, Australia. 'They rely heavily on body reserves from an enormous amount of Antarctic krill to support the physiological costs of the journey and reproduction.'
The highest-latitude calf was found at Port Arthur, Tasmania–about 932 miles further south than it was believed that humpbacks could calf.
When they compared these observations taken over the last decade with historical texts and whaling logbooks, they say that calves born during migration were observed more often before the population crashed due to hunting. Humpback whale numbers in Australia crashed during the peak of the whaling industry, particularly during the 1960s and 1970s.
'I think it's very likely that this pattern has always existed, but the low number of whales obscured it from view,' said McPhee-Frew. 'The Eastern Australia humpback population narrowly escaped extinction, but now there are 30, 40, or 50,000 in this population alone. It doesn't happen overnight, but the recovery of humpback whales, and the return of their full range of behaviors and distribution, just goes to show that with good policies built on good science we can have excellent outcomes.'
For all migratory species, these epic journeys cost a great deal of time and energy. The energy expenditures can leave their young vulnerable to predators. While this particular study can't answer why humpback whales risk migrating if they can give birth further south, it's possible that other factors are driving migration. The benefits of delivering in tropical waters might outweigh the risks of having a potential calf born along the way.
While the data provided by Western Australia's Department of Biodiversity, Conservation, and Attractions pinpointed a possible nursery area in Flinders Bay, it's likely that most calves are born much further north in the tropics.
[ Related: Humpback whales use bubble-nets as 'tools.' ]
According to the team, there are several conservation implications in these findings. Some of the observed calves were injured, so expanded protected areas, awareness campaigns about protective measures boaters and the general public can take, and more research into the habitats that humpbacks use while migrating are critical to safeguarding the calves.
'This study was based on opportunistic observations,' cautioned McPhee-Frew. 'This data is excellent for answering questions like, 'are there newborn whales here?' But we can't stretch the interpretations too far. It might appear that we see more calves the further north we go, or that we have seen more over time. But it could be that there are more people whale-watching in the north, or more cameras and social media sharing in recent years.'
'We can only document what we see,' added study co-author Vanessa Pirotta of Macquarie University in Australia. 'Perhaps there are things happening in our ocean that we are yet to find out.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 hours ago
- Yahoo
Doctor mistakenly implants wrong embryo in IVF patient mix-up
One of Australia's top IVF providers mistakenly implanted a patient with her own embryo instead of her partner's. Monash IVF said the incident occurred on June 5 at a clinic in Melbourne but did not provide further details, such as how it learned of the bungle or what the couple planned to do next. The company said it was supporting the couple, who it did not identify. It marks the second fertility clinic mix-up of its kind in the country, heightening concerns about an industry that did not have much active government oversight until recently. The clinic said the patient's embryo was mistakenly implanted under a treatment plan which called for an embryo from the patient's partner to be transferred. The incident builds on a reputational maelstrom for Monash IVF, which was already reeling from an April disclosure that an Australian woman had given birth to a stranger's baby after a fertility doctor accidentally implanted the wrong embryo in Brisbane in 2023. That mix-up sparked concerns about security protocols at IVF clinics and an industry which is only now in the process of being more regulated. Monash claimed the world's first IVF pregnancy five decades ago and is Australia's second-largest IVF provider, carrying out nearly a quarter of the country's 100,000 assisted reproductive cycles a year, according to industry data. "This mix-up, the second reported incident at Monash IVF, risks shaking confidence not just in one provider but across the entire fertility sector," said Hilary Bowman-Smart, a researcher and bioethicist at the University of South Australia. Shares of Monash IVF were down 25 per cent by mid-session on Tuesday, against a rising broader market. The stock is just over half its value before the April announcement. "We had thought the Brisbane clinic embryo transfer error was an isolated incident," Craig Wong-Pan, an analyst at RBC Capital Markets, said in a client note. "We believe there is now risk of a greater impact of reputational damage and market share losses to MVF's operations." Monash IVF had already hired a lawyer to run an independent investigation after the Brisbane incident, and said on Tuesday it has extended the scope of that investigation. It added that it was installing interim extra verification safeguards to ensure patient confidence. It said it had reported the Melbourne incident to the Victorian Department of Health and industry licensing body, the Reproductive Technology Accreditation Committee (RTAC), part of industry group the Fertility Society of Australia. Victorian health minister Mary-Anne Thomas said the department was investigating the company and the incident. "Families should have confidence that the treatment they are receiving is done to the highest standard," she said. "It is clear Monash IVF has failed to deliver that, which is completely unacceptable." Fertility Society president Petra Wale said the incident would have had an emotional toll on the family, but stressed mistakes in the sector were rare. The society reiterated a call to implement nationally consistent laws around IVF. Currently, the country's IVF industry is regulated by a combination of industry bodies and state and territory health departments, resulting in a governance and compliance system that some groups say is too complex. Reports of transferring the wrong embryo are rare, according to fertility experts, and Monash's Brisbane mix-up was widely reported as the first known case of its kind.
Yahoo
a day ago
- Yahoo
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
BOSTON & SYDNEY, June 09, 2025--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. "The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey," said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. "Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry". BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich. View source version on Contacts MEDIA CONTACTJoAnn Lee / +1 617.936.2937


Business Wire
a day ago
- Business Wire
Berkshire Hathaway Specialty Insurance Launches Life Science, BioTech & Pharmaceutical (LBP) Management Liability Policy in Australia
BOSTON & SYDNEY--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) today announced the introduction of a Management Liability Insurance Policy tailored expressly for Life Science, BioTech and Pharmaceutical (LBP) companies in Australia. 'The new LBP Management Liability Policy reflects our commitment to Australia's thriving life sciences community and our deep understanding of the challenges start-ups face at every stage of their journey,' said Jessica Jefferies, Underwriting Manager, National Brokers, Executive & Professional Lines, BHSI Australia. 'Life Sciences is one of the most promising industries in Australia and we are thrilled to be able to provide an innovative solution to support the industry'. BHSI's new LBP Management Liability Insurance Policy is specifically for the R&D ecosystem – all stakeholders in Australia's diverse and energetic life sciences sector. The new product offers enhanced cover tailored for life sciences companies, with coverage not found in standard Management Liability policies. BHSI's solution will extend cover and ensure Directors, Officers, Scientific and Medical Advisory Boards all get the benefit of cover as they develop cutting-edge solutions globally. With an understanding of the funding requirements, the product provides two key elements of protection, extending cover for private capital raisings, and not excluding cover in the event of the Company's insolvency. With many Australian life sciences companies looking abroad for clinical development, BHSI's offering has the ability to extend protection to U.S. exposures, recognising the frequent pursuit of FDA approvals by Australian firms. The new solution expands BHSI's existing Management Liability policy wording for private companies and not-for-profits. BHSI is a leading market for Directors and Officers Liability insurance for ASX-listed life sciences companies in Australia. This launch extends that expertise and forms part of BHSI's strategy to provide tailored support for biotech and pharmaceutical customers from start-up to scale. To learn more, contact Berkshire Hathaway Specialty Insurance Company (incorporated in Nebraska, USA) ABN 84 600 643 034, AFS Licence No. 466713 ( provides commercial property, casualty, healthcare professional liability, executive and professional lines, transactional liability, surety, marine, travel, programs, accident & health, medical stop loss, homeowners, and multinational insurance. The actual and final terms of coverage for all product lines may vary. Berkshire Hathaway Specialty Insurance Company holds financial strength ratings of A++ from AM Best and AA+ from Standard & Poor's. Based in Boston, Berkshire Hathaway Specialty Insurance has offices in Atlanta, Boston, Chicago, Columbia, Dallas, Houston, Indianapolis, Irvine, Los Angeles, New York, Plymouth Meeting, San Francisco, San Ramon, Seattle, Stevens Point, Adelaide, Auckland, Barcelona, Brisbane, Brussels, Calgary, Cologne, Dubai, Dublin, Frankfurt, Hamburg, Hong Kong, Kuala Lumpur, London, Lyon, Macau, Madrid, Manchester, Melbourne, Milan, Munich, Paris, Perth, Singapore, Stockholm, Sydney, Toronto, and Zurich.